BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Axogen Inc. (NASDAQ:AXGN)

2 posts

Biotech NewsAxogen (AXGN) Surges Toward $26 Target as Nerve Repair Demand Soars 17%

  • BioTech Health X
  • October 12, 2025
Axogen Inc. (NASDAQ:AXGN) is a leading regenerative medicine company focused on advancing the science and clinical practice of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAxogen (AXGN) is Reinventing Nerve Repair—And It Could Make Early Investors Rich

  • BioTech Health X
  • July 18, 2025
Axogen Inc. (NASDAQ:AXGN) is a pioneering medical technology company dedicated to improving the lives of patients suffering from…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • NewAmsterdam Pharma (NAMS) Soars 93.9% in 12 Months
  • Teva Pharma (TEVA) Wins FDA Approval for UZEDY’s Bipolar I Expansion
  • Radiopharm Theranostics (RADX) Halts Trading Ahead of Major Capital Raise
  • Candel Therapeutics (CADL) Boosts Cash to $217M, Prepares for 2026 Prostate Cancer Launch
  • Teladoc (TDOC)’s AI Upgrade Could Be Its Biggest Breakthrough Since Livongo
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 15, 2025
    NewAmsterdam Pharma (NAMS) Soars 93.9% in 12 Months
    • October 15, 2025
    Teva Pharma (TEVA) Wins FDA Approval for UZEDY’s Bipolar I Expansion
    • October 15, 2025
    Radiopharm Theranostics (RADX) Halts Trading Ahead of Major Capital Raise
    • October 15, 2025
    Candel Therapeutics (CADL) Boosts Cash to $217M, Prepares for 2026 Prostate Cancer Launch
    • October 15, 2025
    Teladoc (TDOC)’s AI Upgrade Could Be Its Biggest Breakthrough Since Livongo
Recent Posts
  • Tonix Pharmaceuticals (TNXP) Plunges 20% After FDA Win
    • October 14, 2025
  • AstraZeneca (AZN) Targets $80 Billion Revenue by 2030
    • October 14, 2025
  • Akero Therapeutics (AKRO) Soars 16.52% After Liver Drug Breakthrough Shocks Wall Street
    • October 14, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (476)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top